Is Novartis Planning To Sell Its India Unit?
Drug major Novartis AG has initiated a strategic review of Novartis India Ltd amid reports of putting the India listed business on the block.
"Novartis AG has commenced the strategic review that will include an assessment of its 70.68% shareholding in Novartis India Limited," a Novartis India spokesperson told NDTV Profit. "No decision has yet been taken regarding the eventual outcome. In the meantime, it is business as usual."
Media reports suggest that drugmaker Dr. Reddy's Laboratories Ltd. is in the race to acquire the Novartis AG's stake in Novartis India. Dr. Reddy's declined to comment on NDTV Profit's emailed queries.
In February 2022, the company entered into an exclusive sales and distribution agreement with Dr Reddy's for a few of its established medicines, which include the Voveran® range, the alcium range and Methergine to further broaden access to these medicines beyond the current geographies.
"The combined approach of our focus on collaboration and different business models on ensuring wider access to our medicines has allowed your company to improve volume growth and operating margins. Volume growth of our portfolio distributed by Dr. Reddy's was double digit," Novartis India said in its annual report of 2022-23.
Novartis India reported a net profit of Rs 26.5 crore for the quarter ended December 2023 from Rs 7.6 crore on-year. Its revenue from operations stood at Rs 84.5 crore from Rs 80 crore in the October-December quarter of the last fiscal.
For FY23, its pharma business registered revenue of Rs 378 crore, a m 5% decline over the previous year. Its profit stood at Rs 103 crore during the year.
Shares of Novartis India, with a market capitalisation of Rs 2,556 crore, closed over 13% higher on Friday at settle at Rs 1,035 per share on the BSE as compared to 0.5% rise in benchmark Sensex. The stock has rallied over 72% in the past year.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.